Amarin down as topline contracts in Q4
Source: SeekingAlpha
2026-02-25 10:17:23 ET
More on Amarin
- Amarin expects full-year 2025 revenue in-line with estimates
- Seeking Alpha’s Quant Rating on Amarin
- Historical earnings data for Amarin
- Financial information for Amarin
Read the full article on Seeking Alpha
For further details see:
Amarin down as topline contracts in Q4
Amarin Corporation plc
NASDAQ: AMRN
AMRN Trading
-2.99% G/L:
$13.775 Last:
25,026 Volume:
$13.98 Open:
AMRN Latest News
AMRN Stock Data
$312,618,004
18,426,477
1.2%
30
N/A
Pharmaceuticals
Healthcare
IE
Dublin 2
